Finally, the research revealed 15 different non-[18F]FDG PET criteria: the European Association of Nuclear Medicine (EANM) criteria, the Prostate-Specific Membrane Antigen- Reporting and Data Systems (PSMA-RADS), the PROMISE (miTNM) criteria, the E-PSMA reporting system, the Pro-PET score, and the PRIMARY for PSMA PET imaging interpretation of PCa; PSMA PET Progression (PPP) and RECIP 1.0 as treatment response evaluation criteria for PCa. Here, FOLH1 is linked to posterior cortical atrophy.